Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Source And Potency Of Stem Cells

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic Landscape of Acute Leukemia of Ambiguous Lineage: A Single Cancer Center Experience.

The Journal of molecular diagnostics : JMD·2026

Same author

Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype.

Blood·2026

Same author

Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.

Nature genetics·2026

Same author

Towards evolutionary guided precision medicine of acute myeloid leukemia and Fanconi anemia associated bone marrow failure.

Stem cells translational medicine·2026

Same author

Long-Term Outcomes of Stem Cell Transplant in Older Patients With Acute Myeloid Leukemia Treated With Venetoclax-Based Therapies.

American journal of hematology·2026

Same author

Case Report: Application of <i>ex-vivo</i> drug sensitivity testing to identify personalized treatment options for an adolescent with diffuse midline glioma.

Frontiers in oncology·2025

Same journal

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 22, 2026

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Optimizing stem cell mobilization: lessons learned.

Pamela S Becker¹

¹From the Division of Hematology, Department of Medicine, University of Washington, and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Journal of the National Comprehensive Cancer Network : JNCCN

|October 15, 2014

Summary

This summary is machine-generated.

Granulocyte colony-stimulating factor (G-CSF) effectively mobilizes progenitor cells for transplantation. Plerixafor can enhance yields in patients with limited collection potential, ensuring successful stem cell procurement.

More Related Videos

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Related Experiment Videos

Last Updated: Apr 22, 2026

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Area of Science:

Hematology
Oncology
Cellular Biology

Background:

Granulocyte colony-stimulating factor (G-CSF) is a key growth factor for peripheral blood progenitor cell collection.
Mobilization regimens using G-CSF, alone or post-chemotherapy, typically yield adequate CD34(+) cells for successful engraftment.
Limited progenitor cell yields can occur in patients with extensive prior treatments.

Purpose of the Study:

To evaluate strategies for augmenting progenitor cell collection.
To ensure successful stem cell procurement for autologous and allogeneic transplantation.
To preserve graft integrity in challenging patient populations.

Main Methods:

Utilizing G-CSF as a primary mobilization agent.
Employing leukapheresis for progenitor cell collection.
Administering plerixafor in combination with G-CSF for enhanced mobilization.
Integrating chemotherapy regimens for dual tumor reduction and cell mobilization.

Main Results:

G-CSF administration leads to adequate CD34(+) cell yields for transplantation.
Plerixafor combined with G-CSF successfully augments cell collection in patients with prior extensive therapy.
Chemotherapy regimens can enhance progenitor cell collection while reducing tumor burden.
Modern methods achieve high success rates for adequate stem cell product procurement.

Conclusions:

G-CSF is essential for stem cell mobilization and collection.
Plerixafor offers a valuable option to improve stem cell yields in difficult-to-mobilize patients.
Integrated treatment strategies ensure successful stem cell transplantation outcomes.